
  Mrv0541 02231216162D          

 10  9  0  0  1  0            999 V2000
    3.1895    2.6664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1895    1.8414    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.4750    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7605    1.8414    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    3.9039    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6184    1.8414    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    4.6184    2.6664    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    1.4289    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0474    1.8414    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    5.3329    0.6039    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1  0  0  0
  2  3  1  0  0  0  0
  3  4  1  0  0  0  0
  2  5  1  0  0  0  0
  5  6  1  0  0  0  0
  6  7  1  6  0  0  0
  6  8  1  0  0  0  0
  8  9  1  0  0  0  0
  8 10  2  0  0  0  0
M  END
> <DRUGBANK_ID>
DB02542

> <DRUG_GROUPS>
experimental

> <GENERIC_NAME>
(4s)-5-Fluoro-L-Leucine

> <CHEMICAL_FORMULA>
C6H12FNO2

> <MOLECULAR_WEIGHT>
149.1634

> <EXACT_MASS>
149.085206838

> <IUPAC_NAME>
(2S,4S)-2-amino-5-fluoro-4-methylpentanoic acid

> <IUPAC_TRADITIONAL_NAME>
(4s)-5-fluoro-L-leucine

> <INCHI_IDENTIFIER>
InChI=1S/C6H12FNO2/c1-4(3-7)2-5(8)6(9)10/h4-5H,2-3,8H2,1H3,(H,9,10)/t4-,5-/m0/s1

> <INCHI_KEY>
InChIKey=FHOARJRQRXAPOF-WHFBIAKZSA-N

> <SMILES>
C[C@H](CF)C[C@H](N)C(O)=O

> <JCHEM_ACCEPTOR_COUNT>
3

> <JCHEM_DONOR_COUNT>
2

> <JCHEM_ACIDIC_PKA>
2.52

> <JCHEM_BASIC_PKA>
9.52

> <JCHEM_PHYSIOLOGICAL_CHARGE>
0

> <ALOGPS_LOGP>
-2.4

> <JCHEM_LOGP>
-2.1

> <ALOGPS_LOGS>
-0.38

> <JCHEM_POLARIZABILITY>
14.42

> <JCHEM_POLAR_SURFACE_AREA>
63.32

> <JCHEM_REFRACTIVITY>
34.33

> <JCHEM_ROTATABLE_BOND_COUNT>
4

> <ALOGPS_SOLUBILITY>
6.20e+01 g/l __ 

$$$$
